ABP
Abpro HoldingsยทNASDAQ
--
--(--)
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ABP
Abpro Holdings, Inc.
A cutting-edge biotech company specializing in innovative antibody technology platforms,deeply rooted in the biopharmaceutical sector,focused on developing therapies for major diseases such as oncology,and driving clinical advancement of multiple candidate drugs!
68 Cummings Park Drive, Woburn, MA 01801
--
Abpro Holdings, Inc., was incorporated in Delaware on May 20, 2021. The company is a biotechnology company focused on developing next-generation antibody therapies designed to improve the lives of patients with serious and life-threatening diseases. Abpro focuses on novel antibody construction in immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, Abpro is developing a next-generation antibody pipeline independently or through collaborations with global pharmaceutical and research institutions.
Company Financials
EPS
ABP has released its 2025 Q2 earnings. EPS was reported at -0.05, versus the expected -0.04, missing expectations. The chart below visualizes how ABP has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
